VistaGen Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. VistaGen Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 569% to $1,064,000. The net income raised on -$29,362,000 and profit margin reached -2760%. Total operating expenses were $34,085,000.
Profit Margin
| 2015 | 0 | -13.88M | |
|---|---|---|---|
| 2016 | 0 | -47.22M | |
| 2017 | 1.25M | -10.25M | -820.44% |
| 2018 | 0 | -14.34M | |
| 2019 | 0 | -24.58M | |
| 2020 | 0 | -20.77M | |
| 2021 | 1.08M | -17.93M | -1646.09% |
| 2022 | 1.10M | -47.76M | -4307.19% |
| 2023 | -227K | -59.24M | 26100.44% |
| 2024 | 1.06M | -29.36M | -2759.59% |
VTGN Income Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 1.06M | -227K | 1.10M | 1.08M | 0 | 0 | 0 | 1.25M | 0 | 0 |
Cost of revenue | 0 | 0 | 815.2K | 0 | 103.1K | 91.2K | 0 | 0 | 0 | 0 |
Gross profit | 1.06M | -227K | 293.7K | 1.08M | 0 | -91.2K | 0 | 1.25M | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 20.02M | 44.37M | 35.40M | 12.47M | 13.37M | 17.09M | 7.76M | 5.20M | 3.93M | 2.43M |
Selling and marketing | 0 | 1.90M | 2.79M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 34.08M | 59.04M | 48.65M | 19.02M | 19.97M | 24.53M | 14.19M | 11.49M | 17.85M | 6.67M |
Operating income | -33.02M | -59.26M | -47.77M | -17.93M | -20.80M | -24.55M | -14.19M | -10.24M | -17.85M | -6.77M |
Other income (expenses), net | 3.66M | 26K | 19.9K | 2.2K | 30.1K | -48.7K | -135K | -4.6K | -28.59M | -7.10M |
Income before tax | -29.35M | -59.24M | -47.75M | -17.93M | -20.77M | -24.58M | -14.34M | -10.25M | -47.21M | -13.88M |
Income tax expense | 4K | 6K | 3.4K | 2.6K | 2.6K | 2.6K | 2.4K | 2.4K | 2.3K | 2.4K |
Net income | -29.36M | -59.24M | -47.76M | -17.93M | -20.77M | -24.58M | -14.34M | -10.25M | -47.22M | -13.88M |
Earnings per share | ||||||||||
Basic EPS | -1.52 | -8.51 | -7.24 | -6.25 | -14.21 | -25.83 | 0 | -40.85 | -872.51 | -318.27 |
Diluted EPS | -1.52 | -8.51 | -7.24 | -6.25 | -14.21 | -25.83 | 0 | -40.85 | -872.51 | -315.87 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |